Oscar Minuchin

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients

Julio Wainstein, Muriel Metzger, Mona Boaz et al. · Diabetic Medicine · 2005 · 137 citations

Medicine, Endocrinology, Pharmacotherapy +16

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Different contributions of insulin resistance and beta‐cell dysfunction in overweight Israeli Arabs with IFG and IGT

Muhammad Abdul-Ghani, Muhammad Sabbah, Joseph Kher et al. · Diabetes/Metabolism Research and Reviews · 2005 · 57 citations

Medicine, Endocrinology, Diabetology +13

Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.

Muhammad Abdul‐Ghani, Gamal Nawaf, Fawaz Nawaf et al. · PubMed · 2006 · 48 citations

Medicine, Clinical Sciences, Internal Medicine +12